Search for: "Anda Pharmaceuticals, Inc"
Results 61 - 80
of 604
Sorted by Relevance
|
Sort by Date
15 Feb 2017, 2:49 pm
Watson Pharmaceuticals, Inc., February 10, 2017, Hughes, T.). [read post]
16 Dec 2008, 5:16 am
Sanofi-Synthelabo, Sanofi-Synthelabo, Inc., and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership (collectively, Sanofi) brought suit under 35 U.S.C. [read post]
23 Feb 2012, 8:46 pm
("IPC") and Intellipharmaceutics International Inc. [read post]
12 May 2014, 9:18 am
Anchen Pharmaceuticals, Inc., et al., C.A. [read post]
14 Dec 2006, 6:47 am
Cir. 2006, 05-1313) Impax had originally filed an ANDA with the FDA seeking approval to market generic riluzole (6-trifluoromethoxy-2-benzothiazolamine) tablets for the treatment of ALS and prompting a suit for a declaratory judgment that Impax did not infringe, induce [...] [read post]
29 Jan 2013, 9:21 pm
Barr Laboratories, Inc., interesting. [read post]
3 Apr 2024, 1:07 pm
The Federal Trade Commission (“FTC”) has filed an amicus brief in Teva Branded Pharmaceuticals Products R&D, Inc. v. [read post]
6 Sep 2010, 9:48 pm
Teva Pharmaceuticals USA, Inc. [read post]
12 Apr 2015, 7:45 pm
Supernus Pharmaceuticals, Inc. v. [read post]
3 May 2016, 9:00 pm
Guest Post By: Paul Dietze and Mini Kapoor, Haynes and Boone, LLP[1] On March 18, 2016, the Federal Circuit held that Mylan Pharmaceuticals, Inc. [read post]
30 Jun 2011, 2:13 pm
Patent No. 7,915,307...This action relates to an Abbreviated New Drug Application ("ANDA") filed by Mylan Pharmaceuticals, Inc. with the U.S. [read post]
11 Sep 2008, 4:55 am
Forest Laboratories, Inc. and Merck & Co. v. [read post]
23 Nov 2010, 9:54 pm
Noonan -- The Federal Trade Commission is nothing if not persistent in trying to eliminate "reverse payment" settlements in ANDA litigation, even going so far as to "forum shop" to do so, according to a brief by appellees Unimed Pharmaceuticals LLC, Abbott Products, Inc., and Watson Pharmaceuticals, Inc. [read post]
12 Dec 2010, 9:47 pm
-Florida; Watson Pharma, Inc.; Anda, Inc. [read post]
29 Mar 2020, 9:55 pm
Hospira, Inc. [read post]
13 Sep 2017, 7:44 am
Mylan Pharmaceuticals, Inc., 1-17-cv-00379 (DED September 11, 2017, Order) (Stark, USDJ) [read post]
18 Oct 2012, 1:00 am
Par Pharmaceutical Inc., the Federal Circuit upheld the district court’s determination that the patents at issue were not invalid as obvious and were infringed by the subject Abbreviated New Drug Applications (ANDAs). [read post]
26 Apr 2017, 7:24 am
Luitpold Pharmaceuticals, Inc. et al, 2-16-cv-02290 (NJD April 24, 2017, Order) (Walls, USDJ) [read post]
25 May 2012, 11:32 am
Mylan Pharmaceuticals Inc., C.A. [read post]
26 Nov 2012, 11:00 am
On November 13, 2012, Cumberland Pharmaceuticals Inc. [read post]
